{
  "DOI": "10.1007/s10689-021-00241-5",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-021-00241-5",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003e\u003cjats:italic\u003ePurpose\u003c/jats:italic\u003e: Lobular breast cancer (LBC) accounts for ~ 15% of breast cancer. Here, we studied the frequency of pathogenic germline variants (PGVs) in an extended panel of genes in women affected with LBC. \u003cjats:italic\u003eMethods\u003c/jats:italic\u003e: 302 women with LBC and 1567 without breast cancer were tested for \u003cjats:italic\u003eBRCA1/2\u003c/jats:italic\u003e PGVs. A subset of 134 LBC affected women who tested negative for \u003cjats:italic\u003eBRCA1/2\u003c/jats:italic\u003e PGVs underwent extended screening, including: \u003cjats:italic\u003eATM, CDH1, CHEK2, NBN, PALB2, PTEN, RAD50, RAD51D,\u003c/jats:italic\u003e and \u003cjats:italic\u003eTP53.\u003c/jats:italic\u003e\u003cjats:italic\u003eResults\u003c/jats:italic\u003e: 35 PGVs were identified in the group with LBC, of which 22 were in \u003cjats:italic\u003eBRCA1/2\u003c/jats:italic\u003e. Ten actionable PGVs were identified in additional genes (\u003cjats:italic\u003eATM\u003c/jats:italic\u003e(4), \u003cjats:italic\u003eCDH1\u003c/jats:italic\u003e(1), \u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e(1), \u003cjats:italic\u003ePALB2\u003c/jats:italic\u003e(2) and \u003cjats:italic\u003eTP53\u003c/jats:italic\u003e(2)). Overall, PGVs in three genes conferred a significant increased risk for LBC. Odds ratios (ORs) were: \u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003e: OR = 13.17 (95%CI 2.83–66.38; P = 0.0017), \u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e: OR = 10.33 (95%CI 4.58–23.95; P \u0026lt; 0.0001); and \u003cjats:italic\u003eATM:\u003c/jats:italic\u003e OR = 8.01 (95%CI 2.52–29.92; P = 0.0053). We did not detect an increased risk of LBC for \u003cjats:italic\u003ePALB2, CDH1\u003c/jats:italic\u003e or \u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e. \u003cjats:italic\u003eConclusion\u003c/jats:italic\u003e: The overall PGV detection rate was 11.59%, with similar rates of \u003cjats:italic\u003eBRCA1/2\u003c/jats:italic\u003e (7.28%) PGVs as for other actionable PGVs (7.46%), indicating a benefit for extended panel genetic testing in LBC. We also report a previously unrecognised association of pathogenic variants in \u003cjats:italic\u003eATM\u003c/jats:italic\u003e with LBC.\u003c/jats:p\u003e",
  "alternative-id": [
    "241"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "20 January 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "3 March 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "25 March 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "DGE has received travel grants from AstraZeneca. All other authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Clinical or research consent was given for extended testing of breast cancer associated genes (approval from the North Manchester Research Ethics Committee (reference 09/H1008/81(PROCAS) and 08/H1006/77))."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-8618-2332",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "van Veen",
      "given": "Elke M.",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-8482-5784",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Evans",
      "given": "D. Gareth",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Harkness",
      "given": "Elaine F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Byers",
      "given": "Helen J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ellingford",
      "given": "Jamie M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Woodward",
      "given": "Emma R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bowers",
      "given": "Naomi L.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wallace",
      "given": "Andrew J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Howell",
      "given": "Sacha J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Howell",
      "given": "Anthony",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lalloo",
      "given": "Fiona",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-6382-4678",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Newman",
      "given": "William G.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3184-0817",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Smith",
      "given": "Miriam J.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        3,
        25
      ]
    ],
    "date-time": "2021-03-25T02:02:36Z",
    "timestamp": 1616637756000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        3,
        29
      ]
    ],
    "date-time": "2022-03-29T19:56:17Z",
    "timestamp": 1648583777000
  },
  "funder": [
    {
      "DOI": "10.13039/100014653",
      "award": [
        "IS-BRC-1215-20007"
      ],
      "doi-asserted-by": "publisher",
      "name": "Manchester Biomedical Research Centre"
    },
    {
      "award": [
        "GA19-002"
      ],
      "name": "Prevent Breast Cancer"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        9
      ]
    ],
    "date-time": "2024-04-09T07:06:03Z",
    "timestamp": 1712646363883
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2021,
        3,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2022,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            3,
            25
          ]
        ],
        "date-time": "2021-03-25T00:00:00Z",
        "timestamp": 1616630400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            3,
            25
          ]
        ],
        "date-time": "2021-03-25T00:00:00Z",
        "timestamp": 1616630400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00241-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-021-00241-5/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00241-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "129-136",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        3,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        3,
        25
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/1097-0142(19820701)50:1\u003c171::aid-cncr2820500132\u003e3.0.co;2-m",
      "author": "PP Rosen",
      "doi-asserted-by": "publisher",
      "first-page": "171",
      "issue": "1",
      "journal-title": "Cancer",
      "key": "241_CR1",
      "unstructured": "Rosen PP, Lesser ML, Senie RT, Kinne DW (1982) Epidemiology of breast carcinoma III: relationship of family history to tumor type. Cancer 50(1):171–179. https://doi.org/10.1002/1097-0142(19820701)50:1%3c171::aid-cncr2820500132%3e3.0.co;2-m",
      "volume": "50",
      "year": "1982"
    },
    {
      "author": "LA Cannon-Albright",
      "first-page": "2378",
      "issue": "9",
      "journal-title": "Cancer Res",
      "key": "241_CR2",
      "unstructured": "Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter WP, Skolnick MH (1994) Familiality of cancer in Utah. Cancer Res 54(9):2378–2385",
      "volume": "54",
      "year": "1994"
    },
    {
      "DOI": "10.1016/j.clbc.2019.08.003",
      "author": "E Fountzilas",
      "doi-asserted-by": "publisher",
      "journal-title": "Clin Breast Cancer",
      "key": "241_CR3",
      "unstructured": "Fountzilas E, Konstantopoulou I, Vagena A, Apostolou P, Papadimitriou C, Christodoulou C, Tryfonopoulos D, Manousou K, Delimitsou A, Papamentzelopoulou M, Fountzilas G, Yannoukakos D, Fostira F (2019) Pathology of BRCA1- and BRCA2-associated breast cancers: known and less known connections. Clin Breast Cancer. https://doi.org/10.1016/j.clbc.2019.08.003",
      "year": "2019"
    },
    {
      "author": "SR Lakhani",
      "first-page": "782",
      "issue": "3",
      "journal-title": "Clin Cancer Res",
      "key": "241_CR4",
      "unstructured": "Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Futreal PA, Peto J, Stoppa-Lyonnet D, Bignon YJ, Stratton MR (2000) The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 6(3):782–789",
      "volume": "6",
      "year": "2000"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-18-1102",
      "author": "C Petridis",
      "doi-asserted-by": "publisher",
      "first-page": "1162",
      "issue": "7",
      "journal-title": "Cancer Epidemiol Biomarkers",
      "key": "241_CR5",
      "unstructured": "Petridis C, Arora I, Shah V, Moss CL, Mera A, Clifford A, Gillett C, Pinder SE, Tomlinson I, Roylance R, Simpson MA, Sawyer EJ (2019) Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer. Cancer Epidemiol Biomarkers 28(7):1162–1168. https://doi.org/10.1158/1055-9965.EPI-18-1102",
      "volume": "28",
      "year": "2019"
    },
    {
      "DOI": "10.1111/tbj.13154",
      "author": "Y Ditchi",
      "doi-asserted-by": "publisher",
      "first-page": "16",
      "issue": "1",
      "journal-title": "Breast J",
      "key": "241_CR6",
      "unstructured": "Ditchi Y, Broudin C, El Dakdouki Y, Muller M, Lavaud P, Caron O, Lejri D, Baynes C, Mathieu MC, Salleron J, Benusiglio PR (2019) Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations. Breast J 25(1):16–19. https://doi.org/10.1111/tbj.13154",
      "volume": "25",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s13058-015-0546-7",
      "author": "L Dossus",
      "doi-asserted-by": "publisher",
      "first-page": "37",
      "journal-title": "Breast Cancer Res BCR",
      "key": "241_CR7",
      "unstructured": "Dossus L, Benusiglio PR (2015) Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res BCR 17:37. https://doi.org/10.1186/s13058-015-0546-7",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1136/jmg.2009.067850",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "811",
      "issue": "12",
      "journal-title": "J Med Genet",
      "key": "241_CR8",
      "unstructured": "Evans DG, Lalloo F, Cramer A, Jones EA, Knox F, Amir E, Howell A (2009) Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 46(12):811–817. https://doi.org/10.1136/jmg.2009.067850",
      "volume": "46",
      "year": "2009"
    },
    {
      "DOI": "10.1136/jmg.2007.051268",
      "author": "S Masciari",
      "doi-asserted-by": "publisher",
      "first-page": "726",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "241_CR9",
      "unstructured": "Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D (2007) Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 44(11):726–731. https://doi.org/10.1136/jmg.2007.051268",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.1136/jmedgenet-2012-101472",
      "author": "PR Benusiglio",
      "doi-asserted-by": "publisher",
      "first-page": "486",
      "issue": "7",
      "journal-title": "J Med Genet",
      "key": "241_CR10",
      "unstructured": "Benusiglio PR, Malka D, Rouleau E, De Pauw A, Buecher B, Nogues C, Fourme E, Colas C, Coulet F, Warcoin M, Grandjouan S, Sezeur A, Laurent-Puig P, Moliere D, Tlemsani C, Di Maria M, Byrde V, Delaloge S, Blayau M, Caron O (2013) CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 50(7):486–489. https://doi.org/10.1136/jmedgenet-2012-101472",
      "volume": "50",
      "year": "2013"
    },
    {
      "DOI": "10.1038/bjc.2013.792",
      "author": "C Petridis",
      "doi-asserted-by": "publisher",
      "first-page": "1053",
      "issue": "4",
      "journal-title": "Br J Cancer",
      "key": "241_CR11",
      "unstructured": "Petridis C, Shinomiya I, Kohut K, Gorman P, Caneppele M, Shah V, Troy M, Pinder SE, Hanby A, Tomlinson I, Trembath RC, Roylance R, Simpson MA, Sawyer EJ (2014) Germline CDH1 mutations in bilateral lobular carcinoma in situ. Br J Cancer 110(4):1053–1057. https://doi.org/10.1038/bjc.2013.792",
      "volume": "110",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10689-016-9869-5",
      "author": "G Corso",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "241_CR12",
      "unstructured": "Corso G, Intra M, Trentin C, Veronesi P, Galimberti V (2016) CDH1 germline mutations and hereditary lobular breast cancer. Fam Cancer 15(2):215–219. https://doi.org/10.1007/s10689-016-9869-5",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1053/gast.2001.29611",
      "author": "PD Pharoah",
      "doi-asserted-by": "publisher",
      "first-page": "1348",
      "issue": "6",
      "journal-title": "Gastroenterology",
      "key": "241_CR13",
      "unstructured": "Pharoah PD, Guilford P, Caldas C, International Gastric Cancer Linkage C (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121(6):1348–1353. https://doi.org/10.1053/gast.2001.29611",
      "volume": "121",
      "year": "2001"
    },
    {
      "DOI": "10.1001/jamaoncol.2014.168",
      "author": "S Hansford",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "issue": "1",
      "journal-title": "JAMA Oncol",
      "key": "241_CR14",
      "unstructured": "Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, Schrader KA, Schaeffer DF, Shumansky K, Zogopoulos G, Santos TA, Claro I, Carvalho J, Nielsen C, Padilla S, Lum A, Talhouk A, Baker-Lange K, Richardson S, Lewis I, Lindor NM, Pennell E, MacMillan A, Fernandez B, Keller G, Lynch H, Shah SP, Guilford P, Gallinger S, Corso G, Roviello F, Caldas C, Oliveira C, Pharoah PD, Huntsman DG (2015) Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. JAMA Oncol 1(1):23–32. https://doi.org/10.1001/jamaoncol.2014.168",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.1586/era.09.38",
      "author": "M Ahmed",
      "doi-asserted-by": "publisher",
      "first-page": "1103",
      "issue": "8",
      "journal-title": "Expert Rev Anticancer Ther",
      "key": "241_CR15",
      "unstructured": "Ahmed M, Lalloo F, Evans DG (2009) Update on genetic predisposition to breast cancer. Expert Rev Anticancer Ther 9(8):1103–1113. https://doi.org/10.1586/era.09.38",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.3310/pgfar04110",
      "doi-asserted-by": "publisher",
      "key": "241_CR16",
      "unstructured": "Evans DG, Astley S, Stavrinos P, Harkness E, Donnelly LS, Dawe S, Jacob I, Harvie M, Cuzick J, Brentnall A, Wilson M, Harrison F, Payne K, Howell A (2016). In: Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Programme Grants for Applied Research. Southampton (UK). https://doi.org/10.3310/pgfar04110"
    },
    {
      "DOI": "10.1056/NEJMoa1913948",
      "author": "C Breast Cancer Association",
      "doi-asserted-by": "publisher",
      "journal-title": "N Engl J Med",
      "key": "241_CR17",
      "unstructured": "Breast Cancer Association C, Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, Alvarez N, Herraez B, Fernandez V, Nunez-Torres R, Osorio A, Valcich J, Li M, Torngren T, Harrington PA, Baynes C, Conroy DM, Decker B, Fachal L, Mavaddat N, Ahearn T, Aittomaki K, Antonenkova NN, Arnold N, Arveux P, Ausems M, Auvinen P, Becher H, Beckmann MW, Behrens S, Bermisheva M, Bialkowska K, Blomqvist C, Bogdanova NV, Bogdanova-Markov N, Bojesen SE, Bonanni B, Borresen-Dale AL, Brauch H, Bremer M, Briceno I, Bruning T, Burwinkel B, Cameron DA, Camp NJ, Campbell A, Carracedo A, Castelao JE, Cessna MH, Chanock SJ, Christiansen H, Collee JM, Cordina-Duverger E, Cornelissen S, Czene K, Dork T, Ekici AB, Engel C, Eriksson M, Fasching PA, Figueroa J, Flyger H, Forsti A, Gabrielson M, Gago-Dominguez M, Georgoulias V, Gil F, Giles GG, Glendon G, Garcia EBG, Alnaes GIG, Guenel P, Hadjisavvas A, Haeberle L, Hahnen E, Hall P, Hamann U, Harkness EF, Hartikainen JM, Hartman M, He W, Heemskerk-Gerritsen BAM, Hillemanns P, Hogervorst FBL, Hollestelle A, Ho WK, Hooning MJ, Howell A, Humphreys K, Idris F, Jakubowska A, Jung A, Kapoor PM, Kerin MJ, Khusnutdinova E, Kim SW, Ko YD, Kosma VM, Kristensen VN, Kyriacou K, Lakeman IMM, Lee JW, Lee MH, Li J, Lindblom A, Lo WY, Loizidou MA, Lophatananon A, Lubinski J, MacInnis RJ, Madsen MJ, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Maurer T, Mavroudis D, McLean C, Meindl A, Mensenkamp AR, Michailidou K, Miller N, Mohd Taib NA, Muir K, Mulligan AM, Nevanlinna H, Newman WG, Nordestgaard BG, Ng PS, Oosterwijk JC, Park SK, Park-Simon TW, Perez JIA, Peterlongo P, Porteous DJ, Prajzendanc K, Prokofyeva D, Radice P, Rashid MU, Rhenius V, Rookus MA, Rudiger T, Saloustros E, Sawyer EJ, Schmutzler RK, Schneeweiss A, Schurmann P, Shah M, Sohn C, Southey MC, Surowy H, Suvanto M, Thanasitthichai S, Tomlinson I, Torres D, Truong T, Tzardi M, Valova Y, van Asperen CJ, Van Dam RM, van den Ouweland AMW, van der Kolk LE, van Veen EM, Wendt C, Williams JA, Yang XR, Yoon SY, Zamora MP, Evans DG, de la Hoya M, Simard J, Antoniou AC, Borg A, Andrulis IL, Chang-Claude J, Garcia-Closas M, Chenevix-Trench G, Milne RL, Pharoah PDP, Schmidt MK, Spurdle AB, Vreeswijk MPG, Benitez J, Dunning AM, Kvist A, Teo SH, Devilee P, Easton DF (2021) Breast cancer risk genes – association analysis in more than 113,000 women. N Engl J Med. https://doi.org/10.1056/NEJMoa1913948",
      "year": "2021"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "241_CR18",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. https://doi.org/10.1038/gim.2015.30",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10689-011-9506-2",
      "author": "A Moran",
      "doi-asserted-by": "publisher",
      "first-page": "235",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "241_CR19",
      "unstructured": "Moran A, O’Hara C, Khan S, Shack L, Woodward E, Maher ER, Lalloo F, Evans DG (2012) Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam Cancer 11(2):235–242. https://doi.org/10.1007/s10689-011-9506-2",
      "volume": "11",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmedgenet-2017-104584",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "674",
      "issue": "10",
      "journal-title": "J Med Genet",
      "key": "241_CR20",
      "unstructured": "Evans DG, Harkness EF, Plaskocinska I, Wallace AJ, Clancy T, Woodward ER, Howell TA, Tischkowitz M, Lalloo F (2017) Pathology update to the Manchester Scoring System based on testing in over 4000 families. J Med Genet 54(10):674–681. https://doi.org/10.1136/jmedgenet-2017-104584",
      "volume": "54",
      "year": "2017"
    },
    {
      "DOI": "10.1056/NEJMsr1501341",
      "author": "DF Easton",
      "doi-asserted-by": "publisher",
      "first-page": "2243",
      "issue": "23",
      "journal-title": "N Engl J Med",
      "key": "241_CR21",
      "unstructured": "Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372(23):2243–2257. https://doi.org/10.1056/NEJMsr1501341",
      "volume": "372",
      "year": "2015"
    },
    {
      "key": "241_CR22",
      "unstructured": "Newman WG HK, McBurney H, Searle S, Lalloo F, Evans DG (2011) E-Cadherin (CDH1) exon deletion in lobular breast carcinoma. J Med Genet 48 (1)"
    },
    {
      "DOI": "10.1001/jamaoncol.2018.2956",
      "author": "HM Lu",
      "doi-asserted-by": "publisher",
      "first-page": "51",
      "issue": "1",
      "journal-title": "JAMA Oncol",
      "key": "241_CR23",
      "unstructured": "Lu HM, Li S, Black MH, Lee S, Hoiness R, Wu S, Mu W, Huether R, Chen J, Sridhar S, Tian Y, McFarland R, Dolinsky J, Tippin Davis B, Mexal S, Dunlop C, Elliott A (2019) Association of breast and ovarian cancers with predisposition genes identified by large-scale sequencing. JAMA Oncol 5(1):51–57. https://doi.org/10.1001/jamaoncol.2018.2956",
      "volume": "5",
      "year": "2019"
    },
    {
      "DOI": "10.1093/jnci/djy028",
      "author": "B Weigelt",
      "doi-asserted-by": "publisher",
      "first-page": "1030",
      "issue": "9",
      "journal-title": "J Natl Cancer Inst",
      "key": "241_CR24",
      "unstructured": "Weigelt B, Bi R, Kumar R, Blecua P, Mandelker DL, Geyer FC, Pareja F, James PA, kConFab I, Couch FJ, Eccles DM, Blows F, Pharoah P, Li A, Selenica P, Lim RS, Jayakumaran G, Waddell N, Shen R, Norton L, Wen HY, Powell SN, Riaz N, Robson ME, Reis-Filho JS, Chenevix-Trench G (2018) The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers. J Natl Cancer Inst 110(9):1030–1034. https://doi.org/10.1093/jnci/djy028",
      "volume": "110",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s13058-018-0951-9",
      "author": "AL Renault",
      "doi-asserted-by": "publisher",
      "first-page": "28",
      "issue": "1",
      "journal-title": "Breast Cancer Res BCR",
      "key": "241_CR25",
      "unstructured": "Renault AL, Mebirouk N, Fuhrmann L, Bataillon G, Cavaciuti E, Le Gal D, Girard E, Popova T, La Rosa P, Beauvallet J, Eon-Marchais S, Dondon MG, d’Enghien CD, Lauge A, Chemlali W, Raynal V, Labbe M, Bieche I, Baulande S, Bay JO, Berthet P, Caron O, Buecher B, Faivre L, Fresnay M, Gauthier-Villars M, Gesta P, Janin N, Lejeune S, Maugard C, Moutton S, Venat-Bouvet L, Zattara H, Fricker JP, Gladieff L, Coupier I, Co FA, kConFab I, Chenevix-Trench G, Hall J, Vincent-Salomon A, Stoppa-Lyonnet D, Andrieu N, Lesueur F (2018) Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers. Breast Cancer Res BCR 20(1):28. https://doi.org/10.1186/s13058-018-0951-9",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.prp.2016.05.002",
      "author": "M Christgen",
      "doi-asserted-by": "publisher",
      "first-page": "583",
      "issue": "7",
      "journal-title": "Pathol Res Pract",
      "key": "241_CR26",
      "unstructured": "Christgen M, Steinemann D, Kuhnle E, Langer F, Gluz O, Harbeck N, Kreipe H (2016) Lobular breast cancer: clinical, molecular and morphological characteristics. Pathol Res Pract 212(7):583–597. https://doi.org/10.1016/j.prp.2016.05.002",
      "volume": "212",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.19.02190",
      "author": "S Yadav",
      "doi-asserted-by": "publisher",
      "journal-title": "J Clin Oncol",
      "key": "241_CR27",
      "unstructured": "Yadav S, Hu C, Hart SN, Boddicker N, Polley EC, Na J, Gnanaolivu R, Lee KY, Lindstrom T, Armasu S, Fitz-Gibbon P, Ghosh K, Stan DL, Pruthi S, Neal L, Sandhu N, Rhodes DJ, Klassen C, Peethambaram PP, Haddad TC, Olson JE, Hoskin TL, Goetz MP, Domchek SM, Boughey JC, Ruddy KJ, Couch FJ (2020) Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer. J Clin Oncol. https://doi.org/10.1200/JCO.19.02190",
      "year": "2020"
    },
    {
      "DOI": "10.1001/jamaoncol.2018.6911",
      "author": "AM Blanco",
      "doi-asserted-by": "publisher",
      "first-page": "120",
      "issue": "1",
      "journal-title": "JAMA Oncol",
      "key": "241_CR28",
      "unstructured": "Blanco AM, Topper S, Nussbaum RL (2019) Association between invasive lobular breast cancer and mutations in the mismatch repair gene MSH6. JAMA Oncol 5(1):120–121. https://doi.org/10.1001/jamaoncol.2018.6911",
      "volume": "5",
      "year": "2019"
    },
    {
      "DOI": "10.1038/sj.bjc.6605606",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "1091",
      "issue": "7",
      "journal-title": "Br J Cancer",
      "key": "241_CR29",
      "unstructured": "Evans DG, Moran A, Hartley R, Dawson J, Bulman B, Knox F, Howell A, Lalloo F (2010) Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status. Br J Cancer 102(7):1091–1098. https://doi.org/10.1038/sj.bjc.6605606",
      "volume": "102",
      "year": "2010"
    },
    {
      "DOI": "10.1002/humu.22938",
      "author": "MJ Smith",
      "doi-asserted-by": "publisher",
      "first-page": "250",
      "issue": "3",
      "journal-title": "Hum Mutat",
      "key": "241_CR30",
      "unstructured": "Smith MJ, Urquhart JE, Harkness EF, Miles EK, Bowers NL, Byers HJ, Bulman M, Gokhale C, Wallace AJ, Newman WG, Evans DG (2016) The contribution of whole gene deletions and large rearrangements to the mutation spectrum in inherited tumor predisposing syndromes. Hum Mutat 37(3):250–256. https://doi.org/10.1002/humu.22938",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41586-020-2308-7",
      "author": "KJ Karczewski",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "issue": "7809",
      "journal-title": "Nature",
      "key": "241_CR31",
      "unstructured": "Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O’Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME, Genome Aggregation Database C, Neale BM, Daly MJ, MacArthur DG (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581(7809):434–443. https://doi.org/10.1038/s41586-020-2308-7",
      "volume": "581",
      "year": "2020"
    },
    {
      "DOI": "10.1001/jamanetworkopen.2018.2140",
      "author": "K Manickam",
      "doi-asserted-by": "publisher",
      "first-page": "e182140",
      "issue": "5",
      "journal-title": "JAMA Netw Open",
      "key": "241_CR32",
      "unstructured": "Manickam K, Buchanan AH, Schwartz MLB, Hallquist MLG, Williams JL, Rahm AK, Rocha H, Savatt JM, Evans AE, Butry LM, Lazzeri AL, Lindbuchler DM, Flansburg CN, Leeming R, Vogel VG, Lebo MS, Mason-Suares HM, Hoskinson DC, Abul-Husn NS, Dewey FE, Overton JD, Reid JG, Baras A, Willard HF, McCormick CZ, Krishnamurthy SB, Hartzel DN, Kost KA, Lavage DR, Sturm AC, Frisbie LR, Person TN, Metpally RP, Giovanni MA, Lowry LE, Leader JB, Ritchie MD, Carey DJ, Justice AE, Kirchner HL, Faucett WA, Williams MS, Ledbetter DH, Murray MF (2018) Exome sequencing-based screening for BRCA1/2 expected pathogenic variants among adult biobank participants. JAMA Netw Open 1(5):e182140. https://doi.org/10.1001/jamanetworkopen.2018.2140",
      "volume": "1",
      "year": "2018"
    }
  ],
  "reference-count": 32,
  "references-count": 32,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-021-00241-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Extended gene panel testing in lobular breast cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "21"
}